REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/02/2026
Back to search
Official data from USPTO
BIOMARIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
01/03/2026
Trademark type
Combined
Nice classes
1, 5
Filing date
10/21/2005
Registration date
01/02/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/26/2016
Last transaction
01/03/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
11/30/2004
First use in commerce
11/30/2004
Drawing code
3
Owner type
03
Owner location
Novato, CA
Examiner
JUN,WON KYUNG WENDY
Law office
L30
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the word BIOMARIN with the letter "I" consisting of DNA fragments. The mark is not in color.
Holders and representatives
Holders
BioMarin Pharmaceutical Inc.
Representatives
Gregory J. Chinlund MARSHALL, GERSTEIN & BORUN LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Assays and diagnostic screening kits composed primarily of reagents for scientific analysis and research for diagnosis of disorders and physiological processes and for measurement of disease markers for scientific purposes
Class 5
Pharmaceutical preparations for use in enzyme therapy; pharmaceutical preparations for use in treatment of genetic disorders; pharmaceutical preparations for use in burn and wound debridement or cleaning; pharmaceuticals for treatment of inflammationinfectious diseases and cardiovascular diseases; assays and diagnostic screening kits composed primarily of reagents for clinical and medical use for analysis and diagnosis of disorders and physiological processes and for measurement of disease markers for medical purposes; carbohydrate inhibiting enzymes for use in disease treatment; fungal lytic enzymes for the treatment of fungal infections; pharmaceuticals for treatment of lysosomal storage diseases; pharmaceuticals for treatment of mucopolysaccharidoses; pharmaceuticals for treatment of carbohydrate-inhibiting enzyme disorders; proteins and enzymes for the productionpurification and isolation of biologics for use in the treatment of medical conditions; biologics produced by recombinant DNA technology for use in the treatment of pathological medical conditions
Publications
History of USPTO decisions and trademark events.
27 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/26/2016
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/26/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/26/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/26/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
02/17/2016
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/02/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/30/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/30/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/29/2012
E815
TEAS SECTION 8 & 15 RECEIVED
11/02/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
01/02/2007
PUBO
PUBLISHED FOR OPPOSITION
10/17/2006
NPUB
NOTICE OF PUBLICATION
09/27/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/23/2006
ALIE
ASSIGNED TO LIE
08/18/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/11/2006
XAEC
EXAMINER'S AMENDMENT ENTERED
08/11/2006
GNEA
EXAMINERS AMENDMENT E-MAILED
08/11/2006
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/11/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/31/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/12/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/12/2006
GNRT
NON-FINAL ACTION E-MAILED
05/02/2006
CNRT
NON-FINAL ACTION WRITTEN
05/02/2006
DOCK
ASSIGNED TO EXAMINER
04/25/2006
NWAP
NEW APPLICATION ENTERED
10/25/2005
Continuous trademark protection
Get notified about every new filing that threatens BIOMARIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.